OB
Ollin BiosciencesClinical-stage biopharmaceutical company developing best-in-disease therapies for vision-threatening eye diseases, including a VEGF/Ang2 bispecific antibody in Phase 3 for DME and wet AMD.
2 Pulse stories
S
SanofiSanofi is a global biopharmaceutical company developing and manufacturing medicines and vaccines across specialty care, immunology, oncology, and rare diseases.
2 Pulse stories
Total Raised
$430M
Ollin BiosciencesSanofi
Last ValuationNot disclosed
Biotech
Sector
Biotech
2023
Founded
1973
Chicago, Illinois
HQ
Paris, France
Private
Status
Public (SNY)
Ollin Biosciences investors
ARCH Venture PartnersTCGX (TCG Crossover)Andreessen HorowitzMubadala CapitalMonograph CapitalBlackstone Multi-Asset InvestingCommodore CapitalRA Capital Management
Sanofi investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for Ollin Biosciences and Sanofi.